Please login to the form below

Not currently logged in
Email:
Password:

research costs

This page shows the latest research costs news and features for those working in and with pharma, biotech and healthcare.

NHS England pledges to streamline clinical trial setup

NHS England pledges to streamline clinical trial setup

The new processes will also try to simplify and speed up the process for reimbursements for excess treatment costs in non-commercial research, says NHS England. ... to come together to support high quality research that patients want and need.

Latest news

  • Profit: the ugly, dirty truth? Profit: the ugly, dirty truth?

    The absence of a sustainable market-place to mitigate risk in research and development costs explains why so many global players have left the field. ... It’s not a recipe for delivering the vast investment into antibiotics research that is needed.

  • Is agile working benefiting the employee or the organisation? Is agile working benefiting the employee or the organisation?

    Beyond the obvious business benefit of reduced office costs, research also tells us agile working improves morale, increases staff retention and importantly widens and unlocks a bigger talent pool, wherein a ... Our experience of developing flexible

  • Biologics set to revolutionise the gastrointestinal market Biologics set to revolutionise the gastrointestinal market

    That's according to GBI Research, which predicts an annual growth rate of 4.45% for the therapy area and expects Takeda to take over as market leader from AbbVie by ... biologics. Jennifer Goossens, associate analyst for GBI Research, said: “ Due to

  • BMS to explore new options for its immuno-oncology drug Opdivo BMS to explore new options for its immuno-oncology drug Opdivo

    BMS to explore new options for its immuno-oncology drug Opdivo. Partners with PsiOxis to research its use with enadenotucirev. ... BMS has agreed to an upfront payment of $10m to PsiOxus, with both companies sharing subsequent research costs.

  • Early win for Pfizer as Remicade biosimilar launches in West Europe Early win for Pfizer as Remicade biosimilar launches in West Europe

    are responsible for some of the “ biggest medicinal costs across Europe”, and that these high costs “ can restrict access to treatment”. ... cheaper to help offset the research costs.

More from news
Approximately 1 fully matching, plus 52 partially matching documents found.

Latest Intelligence

  • Cost containment and the German market Cost containment and the German market

    The country provides a growing healthcare market for manufacturers, with a good infrastructure, qualified employees and a number of research institutions enabling a productive knowledge exchange. ... Innovative medicine requires high research and

  • Applying real-world evidence to orphan drugs Applying real-world evidence to orphan drugs

    However, for many rare disease therapies, the research and development (R&D) costs far outweigh the expected revenue once the product is launched. ... In Europe, the EU Committee of Experts on Rare Diseases (EUCERD) and the European Platform for Rare

  • The Maverick: giving medicines away free The Maverick: giving medicines away free

    Why patent it, when it won't work on anyone else?”. He says this model also cuts down on research and development costs, which he claims could be reduced to just ... This would also drastically reduce manufacturing costs. He also wants other

  • The importance of real-world data to the pharma industry The importance of real-world data to the pharma industry

    The past decade has seen global commercial clinical trial activity decline significantly due to slow start-up times, low patient recruitment, and high and variable costs. ... Increasingly RWD can ensure continuing research activities; the need for data

  • Case study: Overcoming resistance Case study: Overcoming resistance

    Post-campaign consumer research showed the campaign reached 29 per cent of the population and generated a positive shift in behaviour. ... That increases pressure and costs for the NHS. Additionally, research shows that people are not aware of the normal

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest from PMHub

  • Is agile working benefiting the employee or the organisation?

    Beyond reduced office costs, research tells us that agile working improves morale, increases staff retention and importantly widens and unlocks a bigger talent pool. ... In this blog Angela draws on her experience and reflects on how the development of

  • AskMED.co.uk

    AskMED.co.uk. AskMED brings medical professionals together online to provide rapid analysis and feedback for industry questions at a fraction of traditional research costs.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics